abstract |
A TGF-β receptor-containing fusion protein and pharmaceutical use thereof. Specifically, a bifunctional fusion protein comprising a PD-1 antibody targeting moiety and a TGF-βRII extracellular region, a pharmaceutical composition comprising the TGF-β receptor-containing fusion protein, and use thereof as an anticancer drug. |